Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Lloydspharmacy sale rumours resurface, with Phoenix as potential buyer

The Phoenix Group – Rowlands’ parent company – is rumoured to be a potential buyer for McKesson’s European business, Bloomberg has reported.

The financial publication reported yesterday (June 22) that, while the details are not yet public, the Phoenix Group is “in talks to acquire” McKesson’s business in Europe – which includes Lloydspharmacy and AAH in the UK.

Sky News reported in February that McKesson is “in talks” to sell its UK pharmacy branches and wholesaler business, due to concerns about the industry’s financial viability.

Spokespersons for Phoenix UK and McKesson UK told C+D today (June 23) that their respective companies do not comment on speculation.

Talks “could still be delayed”

Bloomberg estimates that McKesson Europe and its UK businesses could be valued up to $4 billion (£2.9bn).

Following the press coverage reporting on McKesson’s rumoured intention to sell its UK business earlier this year, McKesson UK CEO Toby Anderson advised branch managers that what was reported is “speculation” and “it is our policy to decline speaking to the press”.

Presenting its fiscal 2020/21 outlook in May last year, McKesson predicted a 20-25% drop in adjusted operating profit across its European pharmaceutical solutions division, which it partly blamed on the “severe social restrictions” in the UK over COVID-19.

McKesson bought Lloydspharmacy’s former parent company Celesio in 2014.

What do you make of this announcement?

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD007237

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel